Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Derin B. Keskin(Dana-Farber Cancer Institute), David A. Reardon(Dana-Farber Cancer Institute)
Nature
December 19, 2018
Cited by 1,419


Related Papers